Pharmacoeconomic Analysis of Drugs Used in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India—A Cost-of-Illness Study-Reference-Cited by-同舟云学术

Pharmacoeconomic Analysis of Drugs Used in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India—A Cost-of-Illness Study

Published:2017-12-11 Issue:4 Volume:5 Page:33
ISSN:2076-3271
Container-title:Medical Sciences
language:en
Short-container-title:Medical Sciences

Author:

Saha Lekha,Kumari Sweta,Khosla Pratibha,Rani Alka,Kaur Sharonjeet

Publisher

MDPI AG

Subject

General Economics, Econometrics and Finance

Link

http://www.mdpi.com/2076-3271/5/4/33/pdf

Reference19 articles.

1. http://www.who.int/ health-accounts/ghed/en/

2. BRIC’s Growing Share of Global Health Spending and Their Diverging Pathways

3. Evolving Health Expenditure Landscape of the BRICS Nations and Projections to 2025

4. Global, regional, and national under-5 mortality, adult mortality, age—Specific mortality, and life expectancy, 1970–2016: A systematic analysis for the Global Burden of Disease Study 2016;Lancet,2017

5. Pneumonia,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacoeconomic Aspects of Treating Childhood Pneumonia - Cost of Illness Study Based on Data from Serbia;Experimental and Applied Biomedical Research (EABR);2024-03-01

2. Health economics matters in the nanomaterial world: Cost-effectiveness of utilizing an inhalable antibacterial nanomaterial for the treatment of multidrug-resistant pneumonia;Technology in Society;2021-08

3. Household economic burden of childhood severe pneumonia in Bangladesh: a cost-of-illness study;Archives of Disease in Childhood;2021-04-27